FDA moves to ban phenylephrine, found in dozens of popular cold medications, after research shows it performs no better than ...
Pro Medicus is in a strong financial position. As of June 2024, it had AUD 155 million in net cash, and we forecast the company to continue holding net cash over our explicit 10-year forecast period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback